Literature DB >> 31370011

Current and future directions of deep brain stimulation for neurological and psychiatric disorders.

Darrin J Lee1, Christopher S Lozano2, Robert F Dallapiazza3, Andres M Lozano2.   

Abstract

Deep brain stimulation (DBS) has evolved considerably over the past 4 decades. Although it has primarily been used to treat movement disorders such as Parkinson's disease, essential tremor, and dystonia, recently it has been approved to treat obsessive-compulsive disorder and epilepsy. Novel potential indications in both neurological and psychiatric disorders are undergoing active study. There have been significant advances in DBS technology, including preoperative and intraoperative imaging, surgical approaches and techniques, and device improvements. In addition to providing significant clinical benefits and improving quality of life, DBS has also increased the understanding of human electrophysiology and network interactions. Despite the value of DBS, future developments should be aimed at developing less invasive techniques and attaining not just symptom improvement but curative disease modification.

Entities:  

Keywords:  ACC = anterior cingulate cortex; AD = Alzheimer’s disease; ADAS-Cog = Alzheimer’s Disease Assessment Scale, Cognitive Subscale; ALIC = anterior limb of the internal capsule; ANT = anterior nucleus of the thalamus; BNST = bed nucleus of the stria terminalis; CMPfc = centromedian–parafascicular complex; DBS = deep brain stimulation; ET = essential tremor; GPi = globus pallidus pars interna; ITP = inferior thalamic peduncle; NAc = nucleus accumbens; OCD = obsessive-compulsive disorder; PAG/PVG = periaqueductal gray/periventricular gray; PD = Parkinson’s disease; PTSD = posttraumatic stress disorder; Parkinson’s disease; STN = subthalamic nucleus; VC/VS = ventral capsule/ventral striatum; VPL/VPM = ventral posterior lateral nucleus/ventral posterior medial nucleus; Vim = ventral intermediate thalamic nucleus; area LC = locus of the caudate neurons; deep brain stimulation; dystonia; epilepsy; essential tremor; functional neurosurgery; nbM = nucleus basalis of Meynert

Mesh:

Year:  2019        PMID: 31370011     DOI: 10.3171/2019.4.JNS181761

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  28 in total

Review 1.  Electrical devices for visual restoration.

Authors:  Tamara Sharf; Tej Kalakuntla; Darrin J Lee; Kimberly K Gokoffski
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

2.  Suppression of Neuronal Firing Following Antidromic High-Frequency Stimulations on the Neuronal Axons in Rat Hippocampal CA1 Region.

Authors:  Yue Yuan; Zhouyan Feng; Gangsheng Yang; Xiangyu Ye; Zhaoxiang Wang
Journal:  Front Neurosci       Date:  2022-06-10       Impact factor: 5.152

Review 3.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

4.  Perceptions of Deep Brain Stimulation for Adolescents with Obsessive-Compulsive Disorder.

Authors:  Saira A Weinzimmer; Sophie C Schneider; Sandra L Cepeda; Andrew G Guzick; Gabriel Lázaro-Muñoz; Elizabeth McIngvale; Wayne K Goodman; Sameer A Sheth; Eric A Storch
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-02-02       Impact factor: 2.576

5.  Lateral Habenula Serves as a Potential Therapeutic Target for Neuropathic Pain.

Authors:  Yu Du; Yu-Xing Wu; Fang Guo; Feng-Hui Qu; Ting-Ting Hu; Bei Tan; Yi Wang; Wei-Wei Hu; Zhong Chen; Shi-Hong Zhang
Journal:  Neurosci Bull       Date:  2021-06-04       Impact factor: 5.271

6.  Neural Processing Dysfunctions During Fear Learning but Not Reward-Related Processing Characterize Depressed Individuals With High Levels of Repetitive Negative Thinking.

Authors:  Heekyeong Park; Namik Kirlic; Rayus Kuplicki; Martin Paulus; Salvador Guinjoan
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2022-01-20

7.  Spatio-molecular domains identified in the mouse subthalamic nucleus and neighboring glutamatergic and GABAergic brain structures.

Authors:  Sylvie Dumas; Maria Papathanou; Åsa Wallén-Mackenzie; Mihaela M Martis Thiele; Bianca Vlcek; Niclas König; Åsa K Björklund
Journal:  Commun Biol       Date:  2020-07-03

Review 8.  Technology of deep brain stimulation: current status and future directions.

Authors:  Joachim K Krauss; Nir Lipsman; Tipu Aziz; Alexandre Boutet; Peter Brown; Jin Woo Chang; Benjamin Davidson; Warren M Grill; Marwan I Hariz; Andreas Horn; Michael Schulder; Antonios Mammis; Peter A Tass; Jens Volkmann; Andres M Lozano
Journal:  Nat Rev Neurol       Date:  2020-11-26       Impact factor: 42.937

9.  Single-Stage Deep Brain Stimulator Placement for Movement Disorders: A Case Series.

Authors:  Arrin Brooks; Alastair T Hoyt
Journal:  Brain Sci       Date:  2021-05-03

10.  Proceedings of the Seventh Annual Deep Brain Stimulation Think Tank: Advances in Neurophysiology, Adaptive DBS, Virtual Reality, Neuroethics and Technology.

Authors:  Adolfo Ramirez-Zamora; James Giordano; Aysegul Gunduz; Jose Alcantara; Jackson N Cagle; Stephanie Cernera; Parker Difuntorum; Robert S Eisinger; Julieth Gomez; Sarah Long; Brandon Parks; Joshua K Wong; Shannon Chiu; Bhavana Patel; Warren M Grill; Harrison C Walker; Simon J Little; Ro'ee Gilron; Gerd Tinkhauser; Wesley Thevathasan; Nicholas C Sinclair; Andres M Lozano; Thomas Foltynie; Alfonso Fasano; Sameer A Sheth; Katherine Scangos; Terence D Sanger; Jonathan Miller; Audrey C Brumback; Priya Rajasethupathy; Cameron McIntyre; Leslie Schlachter; Nanthia Suthana; Cynthia Kubu; Lauren R Sankary; Karen Herrera-Ferrá; Steven Goetz; Binith Cheeran; G Karl Steinke; Christopher Hess; Leonardo Almeida; Wissam Deeb; Kelly D Foote; Michael S Okun
Journal:  Front Hum Neurosci       Date:  2020-03-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.